"100 first" angioconstrictin I radioimmunoassay reagent - Taiwan Registration 20a5599c0bbac4394483f6d14ba4c543
Access comprehensive regulatory information for "100 first" angioconstrictin I radioimmunoassay reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 20a5599c0bbac4394483f6d14ba4c543 and manufactured by DIASOURCE IMMUNOASSAYS S.A.. The authorized representative in Taiwan is TAIWAN LIFE SUPPORT SYSTEMS INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product uses radioimmunoassay to quantitatively detect the content of angioconin I and plasma renin activity in human EDTA plasma in vitro.
A Clinical chemistry and clinical toxicology
A.1085 Angioconstrictin I and renin test system
Input;; QMS/QSD
Dates and Status
Aug 17, 2020
Aug 17, 2025

